Cargando…
Soluble CD137 as a potential biomarker for severe COVID-19
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly pathogenic infection responsible for the world pandemic in 2020. COVID-19 is characterized by an increased number of critically ill patients with a high risk o...
Autores principales: | Marques, Mariana de Oliveira, Abdo, André, Silva, Priscilla Brito, Silva Junior, Amilton, Alves, Lucas Bassolli de Oliveira, Costa, José Victor Gomes, Martin, Josiane, Bachour, Philip, Baiocchi, Otavio C.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262646/ https://www.ncbi.nlm.nih.gov/pubmed/35810991 http://dx.doi.org/10.1016/j.imlet.2022.07.003 |
Ejemplares similares
-
Functional Capacity of Patients with Pacemaker Due to Isolated Congenital
Atrioventricular Block
por: de Oliveira Júnior, Roberto Márcio, et al.
Publicado: (2015) -
Amyloid Cardiomyopathy: Establishing a Patient Referral Center in Brazil
por: Szor, Roberta Shcolnik, et al.
Publicado: (2021) -
CD137L, a driver of harmful inflammation in the nervous system
por: Wong, Hiu Yi, et al.
Publicado: (2023) -
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
por: Faucheux, Lilith, et al.
Publicado: (2023) -
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)